结直肠癌风险评估与精准筛查方法:美丽新世界还是天壤之别?
综述评估当前结直肠癌风险预测模型的现状,指出现行筛查以年龄为唯一标准,精准筛查可结合遗传、生活方式、性别、种族等因素进行风险分层,但仅有少数模型被系统研究用于风险适配的人群筛查,未来需开发可靠预测模型并开展前瞻性人群研究。
要点
- 现行结直肠癌筛查以年龄为主要标准,采用「一刀切」方式。
- 精准筛查可识别高风险组接受更密集筛查,低风险组接受低强度筛查含无创方式。
- 少数风险预测模型经过验证,但极少被系统研究用于风险适配的人群筛查。
核心结论
- 精准结直肠癌筛查可优化资源利用并惠及患者、提供者和医疗系统,但临床实施前需开发适用于全人群的可靠预测模型并开展前瞻性人群研究。
研究设计与样本
- 综述评估当前风险预测模型的现状,并为未来精准结直肠癌筛查的实施提供路线图。
主要发现
- 预测模型可识别高风险组从更密集筛查中获益,低风险组可推荐包含无创方式的较低强度筛查。
- 预测模型除年龄外纳入遗传(如家族结直肠癌史、胚系和多基因风险评分)、生活方式(如吸烟、饮酒、饮食和缺乏运动)、性别和种族民族等公认风险因素。
- 已有多个风险预测模型经过验证,但极少被系统研究用于风险适配的人群结直肠癌筛查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Current colorectal cancer (CRC) screening recommendations take a "one-size-fits-all" approach using age as the major criterion to initiate screening. Precision screening that incorporates factors beyond age to risk stratify individuals could improve on current approaches and optimally use available resources with benefits for patients, providers, and health care systems. Prediction models could identify high-risk groups who would benefit from more intensive screening, while low-risk groups could be recommended less intensive screening incorporating noninvasive screening modalities. In addition to age, prediction models incorporate well-established risk factors such as genetics (eg, family CRC history, germline, and polygenic risk scores), lifestyle (eg, smoking, alcohol, diet, and physical inactivity), sex, and race and ethnicity among others. Although several risk prediction models have been validated, few have been systematically studied for risk-adapted population CRC screening. In order to envisage clinical implementation of precision screening in the future, it will be critical to develop reliable and accurate prediction models that apply to all individuals in a population; prospectively study risk-adapted CRC screening on the population level; garner acceptance from patients and providers; and assess feasibility, resources, cost, and cost-effectiveness of these new paradigms. This review evaluates the current state of risk prediction modeling and provides a roadmap for future implementation of precision CRC screening.
引用
- Kastrinos F, Kupfer SS, Gupta S, et al. Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology. 2023. PMID: 36841490. doi:10.1053/j.gastro.2023.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。